MedTrace Logo

Web-Mediated Risk Assessment for Endoscopic Screening of Gastric Cancer

NCT03484949 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2018-04-18

No results posted yet for this study

Summary

Gastric cancer is one of the most common malignancies in China. Early detection is critical for gastric cancer management. However, the diagnosis rate of patients with early gastric cancer is still low. Therefore, the investigator design this study to access whether pre-endoscopic screening risk assessment of genetic and environmental risk factors could improve early gastric cancer diagnosis rate.

Conditions

Interventions

DIAGNOSTIC_TEST

pre-endoscopic screening risk assessment

pre-endoscopic screening risk assessment

Sponsors & Collaborators

  • Tang-Du Hospital

    collaborator OTHER

  • Xijing Hospital

    collaborator OTHER

  • State Key Laboratory of Cancer Biology

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2019-12-01
Completion
2020-12-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03484949 on ClinicalTrials.gov